{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:05:43Z","timestamp":1760853943284},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"FAPESP - State of S\u00e3o Paulo Research Foundation","award":["2013\/07600-3"],"award-info":[{"award-number":["2013\/07600-3"]}]},{"name":"CAPES - Coordination for the Improvement of Higher Education Personnel","award":["Ph.D. Fellowship","Ph.D. Fellowship"],"award-info":[{"award-number":["Ph.D. Fellowship","Ph.D. Fellowship"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s10822-017-0039-0","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T04:06:13Z","timestamp":1502251573000},"page":"801-816","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development of a pharmacophore for cruzain using oxadiazoles as virtual molecular probes: quantitative structure\u2013activity relationship studies"],"prefix":"10.1007","volume":"31","author":[{"given":"Anacleto S.","family":"de Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo T.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano D.","family":"Andricopulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"key":"39_CR1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","volume":"375","author":"A Rassi Jr","year":"2010","unstructured":"Rassi A Jr, Rassi A, Marin-Neto JA (2010) Chagas disease. Lancet 375:1388\u20131402","journal-title":"Lancet"},{"key":"39_CR2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMra1410150","volume":"373","author":"C Bern","year":"2015","unstructured":"Bern C (2015) Chagas\u2019 disease. N Engl J Med 373:456\u2013466","journal-title":"N Engl J Med"},{"key":"39_CR3","unstructured":"World Health Organization (2016) Investing to overcome the global impact of neglected tropical diseases: third WHO report on neglected tropical diseases. http:\/\/www.who.int\/neglected_diseases\/9789241564540$4en\/ . Accessed 9 Oct 2016"},{"key":"39_CR4","doi-asserted-by":"crossref","first-page":"e52\u2012e54","DOI":"10.1086\/648070","volume":"49","author":"C Bern","year":"2009","unstructured":"Bern C, Montgomery SP (2009) An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49:e52\u2012e54","journal-title":"Clin Infect Dis"},{"key":"39_CR5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","volume":"25","author":"JA Castro","year":"2006","unstructured":"Castro JA, de Mecca MM, Bartel LC (2006) Toxic side effects of drugs used to treat Chagas\u2019 disease (American trypanosomiasis). Hum Exp Toxicol 25:471\u2013479","journal-title":"Hum Exp Toxicol"},{"key":"39_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molbiopara.2014.01.002","volume":"193","author":"MC Campos","year":"2014","unstructured":"Campos MC et al (2014) Benznidazole-resistance in Trypanosoma cruzi: evidence that distinct mechanism can act in concert. Mol Biochem Parasitol 193:17\u201319","journal-title":"Mol Biochem Parasitol"},{"key":"39_CR7","doi-asserted-by":"crossref","first-page":"e1002139","DOI":"10.1371\/journal.ppat.1002139","volume":"7","author":"PS Doyle","year":"2011","unstructured":"Doyle PS et al (2011) The Trypanosoma cruzi protease cruzain mediates immune evasion. PLoS Pathog 7:e1002139","journal-title":"PLoS Pathog"},{"key":"39_CR8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1242\/jcs.111.5.597","volume":"111","author":"JC Engel","year":"1998","unstructured":"Engel JC et al (1998) Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi. J Cell Sci 111:597\u2013606","journal-title":"J Cell Sci"},{"key":"39_CR9","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1128\/AAC.00436-07","volume":"51","author":"PS Doyle","year":"2007","unstructured":"Doyle PS et al (2007) A cysteine protease inhibitor cures Chagas\u2019 disease in an immunodeficient-mouse model of infection. Antimicrob Agents Chemother 51:3932\u20133939","journal-title":"Antimicrob Agents Chemother"},{"key":"39_CR10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.drudis.2015.02.004","volume":"20","author":"K Martinez-Mayorga","year":"2015","unstructured":"Martinez-Mayorga K et al (2015) Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits. Drug Discov Today 20:890\u2013899","journal-title":"Drug Discov Today"},{"key":"39_CR11","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1021\/jm9009229","volume":"52","author":"RS Ferreira","year":"2009","unstructured":"Ferreira RS et al (2009) Divergent modes of enzyme inhibition in a homologous structure-activity series. J Med Chem 52:5005\u20135008","journal-title":"J Med Chem"},{"key":"39_CR12","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.bmc.2009.07.068","volume":"17","author":"JMS Filho","year":"2009","unstructured":"Filho JMS et al (2009) Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents. Bioorg Med Chem 17:6682\u20136691","journal-title":"Bioorg Med Chem"},{"key":"39_CR13","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/jm100488w","volume":"53","author":"RS Ferreira","year":"2010","unstructured":"Ferreira RS et al (2010) Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. J Med Chem 53:4891\u20134905","journal-title":"J Med Chem"},{"key":"39_CR14","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1016\/j.bmc.2012.08.047","volume":"20","author":"JMS Filho","year":"2012","unstructured":"Filho JMS et al (2012) Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice. Bioorg Med Chem 20:6423\u20136433","journal-title":"Bioorg Med Chem"},{"key":"39_CR15","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/cr950066q","volume":"96","author":"GA Patani","year":"1996","unstructured":"Patani GA, LaVoie EJ (1996) Bioisosterism: a rational approach in drug design. Chem Rev 96:3147\u20133176","journal-title":"Chem Rev"},{"key":"39_CR16","doi-asserted-by":"crossref","first-page":"22799","DOI":"10.3390\/molecules201219880","volume":"20","author":"T Kaserer","year":"2015","unstructured":"Kaserer T et al (2015) Pharmacophore models and pharmacophore-based virtual screening: concepts and application exemplified on hydroxysteroid dehydrogenases. Molecules 20:22799\u201322832","journal-title":"Molecules"},{"key":"39_CR17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/qsar.200860197","volume":"28","author":"A Malvezzi","year":"2009","unstructured":"Malvezzi A et al (2009) Pharmacophore model of cruzain inhibitors. QSAR Comb Sci 28:781\u2013784","journal-title":"QSAR Comb Sci"},{"key":"39_CR18","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","volume":"57","author":"A Cherkasov","year":"2014","unstructured":"Cherkasov A et al (2014) QSAR modeling: where have you been? Where are you going to? J Med Chem 57:4977\u20135010","journal-title":"J Med Chem"},{"key":"39_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.chemolab.2016.03.023","volume":"154","author":"MT Scotti","year":"2016","unstructured":"Scotti M T et al (2016) Variable-selection approaches to generate QSAR models for a set of antichagasic semicarbazones and analogues. Chemometr Intell Lab 154:137\u2013149","journal-title":"Chemometr Intell Lab"},{"key":"39_CR20","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1166\/jctn.2015.4042","volume":"12","author":"S Belaidi","year":"2015","unstructured":"Belaidi S et al (2015) Structure activity relationship and quantitative structure-activity relationships modeling of antitrypanosomal activities of alkyldiamine cryptolepine derivatives. J Comput Theor Nanosci 12:2421\u20132427","journal-title":"J Comput Theor Nanosci"},{"key":"39_CR21","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1039\/c1md00163a","volume":"2","author":"O Mendez-Lucio","year":"2011","unstructured":"Mendez-Lucio O et al (2011) 3D-QSAR studies on purine-carbonitriles as cruzain inhibitors: comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). MedChemComm 2:1058\u20131065","journal-title":"MedChemComm"},{"key":"39_CR22","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bmc.2007.10.048","volume":"16","author":"RF Freitas","year":"2008","unstructured":"Freitas RF, Oprea TI, Montanari CA (2008) 2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L. Bioorg Med Chem 16:838\u2013853","journal-title":"Bioorg Med Chem"},{"key":"39_CR23","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/14756360701810322","volume":"23","author":"RVC Guido","year":"2008","unstructured":"Guido RVC et al (2008) Structure-activity relationships for a class of selective inhibitors of the major cysteine protease from Trypanosoma cruzi. J Enzym Inhib Med Chem 23:964\u2013973","journal-title":"J Enzym Inhib Med Chem"},{"key":"39_CR24","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0960-894X(02)00189-0","volume":"12","author":"CR Rodrigues","year":"2011","unstructured":"Rodrigues CR et al (2011) CoMFA and HQSAR of acylhydrazide cruzain inhibitors. Bioorg Med Chem Lett 12:1537\u20131541","journal-title":"Bioorg Med Chem Lett"},{"key":"39_CR25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/qsar.200510161","volume":"25","author":"JT Leonard","year":"2006","unstructured":"Leonard JT, Roy K (2006) On selection of training and test sets for the development of predictive QSAR models. QSAR Comb Sci 25:235\u2013251","journal-title":"QSAR Comb Sci"},{"key":"39_CR26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/mp300466n","volume":"10","author":"DJ Wood","year":"2013","unstructured":"Wood DJ, Davis AM (2013) Quantitative structure-activity relationship models that stand the test of time. Mol Pharm 10:1183\u20131190","journal-title":"Mol Pharm"},{"key":"39_CR27","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.4155\/fmc-2016-0093","volume":"8","author":"SJ Dixon","year":"2016","unstructured":"Dixon SJ et al (2016) AutoQSAR: an automated machine learning tool for best-practice. QSAR modeling. Future Med Chem 8:1825\u20131839","journal-title":"Future Med Chem"},{"key":"39_CR28","unstructured":"Schr\u00f6dinger Release 2016-2 (2016) Small-Molecule Drug Discovery suite, Schr\u00f6dinger, LLC, New York"},{"key":"39_CR29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jmgm.2010.05.008","volume":"29","author":"J Duan","year":"2010","unstructured":"Duan J et al (2010) Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods. J Mol Graph Model 29:157\u2013170","journal-title":"J Mol Graph Model"},{"key":"39_CR30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/ci100062n","volume":"50","author":"M Sastry","year":"2010","unstructured":"Sastry M et al (2010) Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments. J Chem Inf Model 50:771\u2013784","journal-title":"J Chem Inf Model"},{"key":"39_CR31","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/ci400250c","volume":"53","author":"Y An","year":"2013","unstructured":"An Y, Sherman W, Dixon SL (2013) Kernel-based partial least squares: application to fingerprint-based QSAR with model visualization. J Chem Inf Model 53:2312\u20132321","journal-title":"J Chem Inf Model"},{"key":"39_CR32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10822-006-9082-y","volume":"20","author":"NJ Richmond","year":"2006","unstructured":"Richmond NJ et al (2006) GALAHAD: 1. Pharmacophore identification by hypermolecular alignment of ligands in 3D. J Comput Aided Mol Des 20:567\u2013587","journal-title":"J Comput Aided Mol Des"},{"key":"39_CR33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","volume":"15","author":"SY Yang","year":"2010","unstructured":"Yang SY (2010) Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov Today 15:444\u2013450","journal-title":"Drug Discov Today"},{"key":"39_CR34","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/qsar.200730163","volume":"27","author":"W Long","year":"2008","unstructured":"Long W et al (2008) 3D-QSAR studies on a class of IKK-2 inhibitors with GALAHAD used to develop molecular alignment models. QSAR Comb Sci 27:1113\u20131119","journal-title":"QSAR Comb Sci"},{"key":"39_CR35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2015","unstructured":"Harder E et al (2015) OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput 12:281\u2013296","journal-title":"J Chem Theory Comput"},{"key":"39_CR36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM et al (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234","journal-title":"J Comput Aided Mol Des"},{"key":"39_CR37","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177\u20136196","journal-title":"J Med Chem"},{"key":"39_CR38","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750\u20131759","journal-title":"J Med Chem"},{"key":"39_CR39","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749","journal-title":"J Med Chem"},{"key":"39_CR40","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF et al (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612","journal-title":"J Comput Chem"},{"key":"39_CR41","unstructured":"SYBYL\u00ae-X Suite Molecular Modeling from Sequence through Lead Optimization, version 2.0, Certara USA, Inc"},{"key":"39_CR42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/1573409910666140410111043","volume":"10","author":"CC Melo-Filho","year":"2014","unstructured":"Melo-Filho CC, Braga RC, Andrade CH (2014) 3D-QSAR approaches in drug design: perspectives to generate reliable CoMFA models. Curr Comput Aided Drug Des 10:148\u2013159","journal-title":"Curr Comput Aided Drug Des"},{"key":"39_CR43","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/qua.24481","volume":"113","author":"AD Bochevarov","year":"2013","unstructured":"Bochevarov AD et al (2013) Jaguar: a high-performance quantum chemistry software program with strengths in life and materials sciences. Int J Quantum Chem 113:2110\u20132142","journal-title":"Int J Quantum Chem"},{"key":"39_CR44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1021\/ct049880o","volume":"1","author":"GA Kaminski","year":"2005","unstructured":"Kaminski GA et al (2005) Pseudospectral local second-order Mollet-Plesset methods for computation of hydrogen bonding energies of molecular pairs. J Chem Theory Comput 1:248\u2013254","journal-title":"J Chem Theory Comput"},{"key":"39_CR45","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1897\/01-627","volume":"22","author":"JD Walker","year":"2003","unstructured":"Walker JD et al (2003) Guidelines for developing and using quantitative structure-activity relationships. Environ Toxicol Chem 22:1653\u20131665","journal-title":"Environ Toxicol Chem"},{"key":"39_CR46","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1351\/PAC-REC-12-05-10","volume":"85","author":"GR Desiraju","year":"2013","unstructured":"Desiraju GR et al (2013) Definition of the halogen bond (IUPAC recommendations 2013). Pure Appl Chem 85:1711\u20131713","journal-title":"Pure Appl Chem"},{"key":"39_CR47","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1021\/acs.chemrev.5b00484","volume":"116","author":"G Cavallo","year":"2016","unstructured":"Cavallo G et al (2016) The halogen bond. Chem Rev 116:2478\u20132601","journal-title":"Chem Rev"},{"key":"39_CR48","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1021\/jm3012068","volume":"56","author":"R Wilckern","year":"2012","unstructured":"Wilckern R et al (2012) Principles and applications of halogen bonding in medicinal chemistry and chemical biology. J Med Chem 56:1363\u20131388","journal-title":"J Med Chem"},{"key":"39_CR49","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/jm401709b","volume":"57","author":"RS Ferreira","year":"2014","unstructured":"Ferreira RS et al (2014) Synthesis, biological evaluation, and structure\u2013activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents. J Med Chem 57:2380\u20132392","journal-title":"J Med Chem"},{"key":"39_CR50","doi-asserted-by":"crossref","first-page":"11450","DOI":"10.1021\/ja001901a","volume":"122","author":"S Tsuzuki","year":"2000","unstructured":"Tsuzuki S (2000) Origin of the attraction and directionality of the NH\/\u03c0 interaction: comparison with OH\/\u03c0 and CH\/\u03c0 interactions. J Am Chem Soc 122:11450\u201311458","journal-title":"J Am Chem Soc"},{"key":"39_CR51","doi-asserted-by":"crossref","first-page":"10163","DOI":"10.1021\/jp064206j","volume":"110","author":"S Tsuzuki","year":"2006","unstructured":"Tsuzuki S (2006) Magnitude and directionality of the interaction energy and aliphatic CH\/\u03c0 interaction: significant difference from hydrogen bond. J Phys Chem A 110:10163\u201310168","journal-title":"J Phys Chem A"},{"key":"39_CR52","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1021\/cr200060g","volume":"11","author":"EJ Barreiro","year":"2011","unstructured":"Barreiro EJ, Kummerle AE, Fraga CAM (2011) The methylation effect in medicinal chemistry. Chem Rev 11:5215\u20135246","journal-title":"Chem Rev"},{"key":"39_CR53","doi-asserted-by":"crossref","first-page":"e2370","DOI":"10.1371\/journal.pntd.0002370","volume":"7","author":"HJ Wiggers","year":"2013","unstructured":"Wiggers HJ (2013) Non-peptidic cruzain inhibitors with Trypanocidal activity discovered by virtual screening and in vitro assay. PLoS Negl Trop Dis 7:e2370","journal-title":"PLoS Negl Trop Dis"},{"key":"39_CR54","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ejmech.2012.05.041","volume":"54","author":"SA Carvalho","year":"2012","unstructured":"Carvalho SA et al (2012) Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antirypanosomal agents. Eur J Med Chem 54:512\u2013521","journal-title":"Eur J Med Chem"},{"issue":"1","key":"39_CR55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/14756360902941058","volume":"25","author":"GH Trossini","year":"2010","unstructured":"Trossini GH et al (2010) Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi. J Enzym Inhib Med Chem 25(1):62\u201367","journal-title":"J Enzym Inhib Med Chem"},{"issue":"12","key":"39_CR56","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/cmdc.201500385","volume":"11","author":"E Aguilera","year":"2016","unstructured":"Aguilera E et al (2016) Potent and selective inhibitors of Trypanosoma cruzi triosephosphate isomerase with concomitant inhibition of cruzipain: inhibition of parasite growth through multitarget activity. ChemMedChem 11(12):1328\u20131338","journal-title":"ChemMedChem"},{"issue":"6","key":"39_CR57","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1021\/jm301749y","volume":"56","author":"MF Sassano","year":"2103","unstructured":"Sassano MF et al (2103) Colloidal aggregation causes inhibition of G protein-coupled receptors. J Med Chem 56(6):2406\u20132414","journal-title":"J Med Chem"},{"issue":"6","key":"39_CR58","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.bmc.2017.02.009","volume":"25","author":"SFP Braga","year":"2017","unstructured":"Braga SFP et al (2017) Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification. Bioorg Med Chem 25(6):1889\u20131890","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"39_CR59","doi-asserted-by":"crossref","first-page":"14595","DOI":"10.3390\/molecules200814595","volume":"20","author":"M Couto","year":"2015","unstructured":"Couto M et al (2015) 2-H-[1,2]Dithiole as a new anti-Trypanosoma cruzi chemotype: biological and mechanism of action studies. Molecules 20(8):14595\u201314610","journal-title":"Molecules"},{"issue":"11","key":"39_CR60","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1021\/np500453x","volume":"77","author":"MCM Burger","year":"2014","unstructured":"Burger, MCM et al (2014) Structures and bioactivities of dihydrochalcones from Metrodorea stipularis. J Nat Prod 77(11):2418\u20132422","journal-title":"J Nat Prod"},{"issue":"4","key":"39_CR61","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00044-016-1776-7","volume":"26","author":"RAM Serafim","year":"2017","unstructured":"Serafim RAM et al (2017) Molecular modeling and structure-activity relationships studies of bioisoster hybrids on N-acylhydrazone. Med Chem Res 26(4):760\u2013769","journal-title":"Med Chem Res"},{"issue":"18","key":"39_CR62","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1016\/j.bmc.2016.07.013","volume":"24","author":"EF Silva-Junior","year":"2016","unstructured":"Silva-Junior EF et al (2016) Design, synthesis, molecular docking and biological evaluation of thiophen-2-iminothiazolidine derivatives for use against Trypanosoma cruzi. Bioorg Med Chem 24(18):4228\u20134240","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"39_CR63","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/ci400284v","volume":"53","author":"CL Bellara","year":"2013","unstructured":"Bellara CL et al (2013) Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effects. J Chem Inf Model 53(9):2402\u20132408","journal-title":"J Chem Inf Model"},{"key":"39_CR64","doi-asserted-by":"crossref","first-page":"12256","DOI":"10.1002\/anie.201303207","volume":"52","author":"H Schonherr","year":"2013","unstructured":"Schonherr H, Cernak T (2013) Profound methyl effects in drug discovey and a call for new C\u2013H methylation reactions. Angew Chem Int Ed 52:12256\u201312267","journal-title":"Angew Chem Int Ed"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-017-0039-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-017-0039-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-017-0039-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T22:24:48Z","timestamp":1659306288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-017-0039-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1007\/s10822-017-0039-0","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,9]]}}}